84 related articles for article (PubMed ID: 7482326)
21. [Comparative efficacy of the long-term use of long-acting nitroglycerin (sustak) and molsidomine after myocardial infarct complicated by heart failure].
Dormidontov EN; Petrov DV
Kardiologiia; 1986 Sep; 26(9):85-9. PubMed ID: 3097371
[TBL] [Abstract][Full Text] [Related]
22. [Parenteral administration of molsidomine].
Klaus W
Med Klin (Munich); 1994 Jul; 89 Suppl 2():1. PubMed ID: 7968891
[No Abstract] [Full Text] [Related]
23. [Intravenous molsidomine administration in heart failure. Part I: Dose-response relationship with reference to hemodynamic parameters].
Störk T; Möckel M; Danne O; Müller R; Eichstädt H; Hochrein H
Med Klin (Munich); 1994 Jul; 89 Suppl 2():47-9. PubMed ID: 7968903
[No Abstract] [Full Text] [Related]
24. SIN-1 has no direct myocardial anti-ischemic action.
Kober G; Bender M; Vallbracht C; Sievert H; Klepzig H
Clin Cardiol; 1993 Oct; 16(10):717-22. PubMed ID: 8222384
[TBL] [Abstract][Full Text] [Related]
25. [The optimization of the hemodynamic characteristics in patients with ischemic heart disease and circulatory failure by using a substrate-coenzyme complex].
Vizir AD; Dunaev VV; Berezin AE; Kraĭdashenko OV
Lik Sprava; 1997; (5):53-6. PubMed ID: 9491697
[TBL] [Abstract][Full Text] [Related]
26. [A comparative evaluation of the antianginal action of commercially and noncommercially produced validol in neurocirculatory dystonia and stenocardia].
Bondarenko IP; Liashenko MM; Chirkov SN; Ermakovich II
Lik Sprava; 1996; (3-4):110-3. PubMed ID: 9035841
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of oral and intravenous administration of molsidomine in patients with heart failure].
Grosse-Heitmeyer W; Huber T; Grewe R
Med Klin (Munich); 1994 Jul; 89 Suppl 2():54-7. PubMed ID: 7968905
[No Abstract] [Full Text] [Related]
28. [Acute hemodynamic effects of intravenous administration of molsidomine in secondary pulmonary hypertension and right heart failure].
Jahed MM
Med Klin (Munich); 1994 Jul; 89 Suppl 2():58-61. PubMed ID: 7968906
[No Abstract] [Full Text] [Related]
29. Clinical pharmacokinetics of molsidomine.
Rosenkranz B; Winkelmann BR; Parnham MJ
Clin Pharmacokinet; 1996 May; 30(5):372-84. PubMed ID: 8743336
[TBL] [Abstract][Full Text] [Related]
30. [Clinical and hemodynamic effect of molsidomine in patients with unstable angina pectoris].
Beloev I; Tomov I; Elenkova A; Terzieva L
Vutr Boles; 1982; 21(3):62-9. PubMed ID: 6810552
[TBL] [Abstract][Full Text] [Related]
31. [Intravenous molsidomine administration in heart failure. Part II: Comparison with nitroglycerin and effectiveness in nitrate tolerance].
Störk T; Möckel M; Danne O; Müller R; Eichstädt H; Hochrein H
Med Klin (Munich); 1994 Jul; 89 Suppl 2():50-3. PubMed ID: 7968904
[No Abstract] [Full Text] [Related]
32. [Effectiveness of using corvaton on patients with unstable stenocardia].
Vakaliuk IP
Vrach Delo; 1984 Nov; (11):18-21. PubMed ID: 6442043
[No Abstract] [Full Text] [Related]
33. [Effect of korvaton and korinfar on systemic circulation in heart failure patients].
Koshlia VI
Vrach Delo; 1986 Aug; (8):23-5. PubMed ID: 3776152
[No Abstract] [Full Text] [Related]
34. [Value of linsidomine (SIN 1) in the evaluation of myocardial viability by 201-Tl scintigraphy after exertion].
Vacheron A; de Vernejoul P
C R Acad Sci III; 1994 May; 317(5):452-6. PubMed ID: 7994624
[TBL] [Abstract][Full Text] [Related]
35. The effect of some antianginal drugs on the myocardial perfusion in patients with ischaemic heart disease.
Gasilin VS; Kramer AA; Samoilenko LE
Cor Vasa; 1981; 23(6):429-38. PubMed ID: 6800695
[TBL] [Abstract][Full Text] [Related]
36. Stability behaviour of molsidomine-containing pellet formulations.
Laicher A; Jünger H; Klemm FH
J Pharm Pharmacol; 1997 Feb; 49(2):131-4. PubMed ID: 9055182
[TBL] [Abstract][Full Text] [Related]
37. Interactions of vasodilators with calcium entry- and beta-blockers in patients with coronary heart disease.
Stauch M; Haerer W; Henze E; Hermann T; Kohler J; Kress P; Adam WE
Z Kardiol; 1986; 75 Suppl 3():106-11. PubMed ID: 3026101
[TBL] [Abstract][Full Text] [Related]
38. [Effect of the acute administration of molsidomine in refractory congestive heart failure. A double-blind randomized non-invasive study].
Coletta C; Galati A; Carunchio A; Salustri A; Bordi L; Fera MS
G Ital Cardiol; 1986 Mar; 16(3):232-6. PubMed ID: 3755412
[TBL] [Abstract][Full Text] [Related]
39. [Molsidomine in chronic heart failure with liver congestion--oral or intravenous therapy?].
Grosse-Heitmeyer W; Huber T; Ostrowski J
Med Klin (Munich); 1993 Jan; 88(1):21-5. PubMed ID: 8437528
[TBL] [Abstract][Full Text] [Related]
40. Acute effects of intravenous nicorandil on hemodynamics in patients hospitalized with acute decompensated heart failure.
Tanaka K; Kato K; Takano T; Katagiri T; Asanoi H; Nejima J; Nakashima M; Kamijo T; Sakanashi M
J Cardiol; 2010 Nov; 56(3):291-9. PubMed ID: 20709498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
